Lékařská fakulta, Masarykova Univerzita

Výsledky: V humánní medicíně jsou zatím zprávy o bezpečném ošetření lézí jater a ledvin, nejsou známy dlouhodobé výsledky, odpověď na léčbu ani recidivy. Zvláště u centrálně uložených neresekabilních lézí jater, případně pro využití u neresekabilního cholangiocelulárního karcinomu extrahepatálních žlučových cest, případně pankreatu by mohla mít oproti ostatním ablačním technikám řadu výhod.
Literatura:
ALZA Pharmaceuticals Doxil Package Insert. Mountain View, CA, USA, 2000.

Abdalla EK, Denys A, Chevalier P, et al. Total and segmental liver volume variations: implications for liver surgery. Surgery 2004, 135: 404-10

Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outomes following hepatic resection, readiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004, 239: 818-25

Adam R, Pascal G, Castaing D et al. Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052–1061; discussion 1061–1064.

Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 2004;240:644–657; discussion 657–658.

Adams J, Kauffman M. Development of the Proteasome Inhibitor Velcade™ (Bortezomib). Cancer Invest. 2004, 22 (2): 304-11.

Alencar, H. et al. Colonic adenocarcinomas: nearinfrared microcatheter imaging of smart probes for early detection—study in mice. Radiology 2007, 244, 232–238.

Al-Hajj M, Clarke MF.Oncogene 2004, 23: 7274-82

Andrews SC, Walker RJ, Ackerman LA, et al. Hepatic radioembolization wih yttrium-90 containing glass microspheres: preliminary results and clinical follow up. J Nucl Med 1994, 35: 1644-46

Arai Y, Endo T, Sone Y, Tohyama N, et al. : Management of patients with unresectable liver metastases from colorectal and gastric cancer emppploying an implantable port systém. Cancer Chemother Pharmacol, 31, 1992, p. 99-102

Artemov, D., Mori, N., Ravi, R. & Bhujwalla, Z. M. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 2003, 63, 2723–2727.

Austin-Seymour M, Munzenrider J, Goitein M, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of skull. J Neurosurg. 1989;70:13-17.

Ayav A, Bachellier P, Habib N, et al. Ompact of radiofrequency assisted hepatectomy for reduction of transfusion requirements. available on-line on sciencedirect.com Jan 19 2007.

Ayav A, Habib N, Jiao LR, Portal hypertension secondary to 90yttrium microspheres: an unknown complication, J Clin Oncol 2005, 23: 8275–8276.

Azad NS, Posadas EM, Kwitkowski VE, et al. Increased efficacy and toxicity with combination anti-VEGF therapy using sorafenib and bevacizumab. Proc Am Soc Clin Oncol. 2006;24:121s. Abstract 3004.

J.S. Azagra, M. Gowergen, E. Gilbart and D. Jacobs, Laparoscopic anatomical left lateral segmentectomy—technical aspects. Surg Endosc 10 (1996), pp. 758–761.

Bachellier P, Ayav A, Pai M, et al. Laparoscopic liver resection assisted with radiofrequency. available on-line on sciencedirect.com 20 March 2007

Bagia JS, Perera DS, Morris DL. Renal impairment in hepatic cryotherapy. Cryobiology 1998;36:263–267.

Barber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005, 23: 1358-64

Barclay L. Photodynamic therapy Improves Survival in Nonresectable Cholangiocarcinoma. Medscape Medical News 2003.

Becker, A. et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nature Biotech. 2001, 19, 327–331.

Behrns KE, Tsiotos GG, DeSouza NF et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292–298.

Belghiti J, Hiramatsu K, Benoist S et al. Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection. J Am Coll Surg 2000;191:38–46.

Belhocine, T. et al. Increased uptake of the apoptosisimaging agent 99mTc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin. Cancer Res. 2002, 8, 2766–2774.

Belli G., Fantini C., D Agosto A. et. Al Laparoscopic left lateral hepatic lobectomy: a safer and faster technique. J Hepatobiliary Pancreat. Surg 2006; 13:149-154

Benoist S, Brouquet A, Penna C et al. Complete response of colorectal liver metastases after chemotherapy: Does it mean cure? J Clin Oncol 2006;24: 3939–3945.

Berends F.J., Meijer S., Prevoo W. et al. Technical considerations in laparoscopic liver surgery Surgical Endoscopy 2001; 15:794-798

Biertho L, A. Waage and M. Gagner, Laparoscopic hepatectomy, Ann Chir 127 (2002), pp. 164–167.

Bilchik JA, et al. Letter to the Editor. J Clin Oncol 2006, p.2217-2218

Bismuth H, Adam R., Levi F. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Annals of Surgery 1996, 224, 4: 509-520.

Blackwell TS, Debelak JP, Venkatakrishnan A, et al. Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery 1999;126:518–526.

Boersma, H. H. et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J. Nucl. Med. 2005, 46, 2035–2050.

Bonvini P, Zorzi E, Basso G, Rosolen A . Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma. Leukemia 2007, 21 (4): 838-42.

Boone, J. M., Velazquez, O. & Cherry, S. R. Smallanimal X-ray dose from micro-CT. Mol. Imaging 2004, 3, 149–158

Bottini M, Cerignoli F, Dawson MI, et al. Full-length single-walled carbon nanotubes decorated with streptavidinconjugated quantum dots as multivalent intracellular fluorescent nanoprobes. Biomacromolecules. 2006;7:2259–2263.

Bown SG. Phototherapy in tumors. World J Surg 1983, 7: 700-709

Brigger I, Morizet J, Aubert G, et al. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres displays a combined effect for brain tumor targeting. J. Pharmacol. Exp. Ther. 2002, 303: 928–936.

Brindle K. New approaches for imaging tumour responses to treatment.Nature Reviews Cancer 2008,8 : 94-107. doi:10.1038/nrc2289

Bulte, J. W. M. et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA 1999, 96, 15256–15261.

Burdío F, Guemes A, Burdío JM, et al. Bipolar saline-enhanced electrode for radiofrequency ablation: results of experimental study of in vivo porcine model. Radiology 2003, 229: 447-56.

Burpee SE, M. Kurian, Y. Murakame, S. Benevides and M. Gagner, The metabolic and immune response to laparoscopic versus open liver resection. Surg Endosc 16 6 (2002), pp. 899–904.

Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest. 1999;116:1313-1319

Cady B, Jenkins R, Steele GD jr, et al. Sugical margin in hepatic reection fo colorectal metastases. A critical and improvable determinant of outcome. Ann Surg 1998, 227,: 566-71

Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A 2002;99: 10567-70

Calarota, S. A. & Weiner, D. B. Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants. Immunol. Rev. 2004, 199, 84–99

Calin GA, Dumitru CD, Shimizu M, et al. Proc. Natl. Acad. Sci. USA 2002, 99: 155.

Calin GA, Sevignani C, Dumitru CD, et al. Proc. Natl. Acad. Sci. USA 2004 101: 2999.

Calvo P, Gouritin B, Chacun H, et al. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm. Res. 2001, 18: 1157–1166.

Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 2000, 407, 249–257.

Cauchon, N. et al. PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 247–258.

Cherqui D, O. Soubrane and E. Husson et al., Laparoscopic living donor hepatectomy for liver transplantation in children, Lancet 359 (2002), pp. 392–396.

Cohen MC, Minsky BD, Schilsky RI. Cancer of the colon. In: De Vita VT, Hellman s, Rosenberg SA (eds.). Cancer, principles and practice in oncology. 5th edition, Philadelphia 1993, JB Lippincott: 1144-97

Collins AT et al. 2005, Cancer Res 65: 10946-51

Cooper IS. Cryogenic surgery: a new method of destruction or exstirpation of benign or malignant tissues. N Engl J Med 1963, 268: 743-49

Correale P, Cusi M, Tsang K, et al. Chemo-Immunotherapy of Metastatic Colorectal Carcinoma With Gemcitabine Plus FOLFOX 4 Followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Induces Strong Immunologic and Antitumor Activity in Metastatic Colon Cancer Patients. Journal of Clinical Oncology. 2005;23(35):8950-8958.

Corsten MF, Hofstra L, Narula J, Reutelingsperger CP. Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. Cancer Res. 2006, 66, 1255–1260.

Couvreur P, Kante B, Lenaerts V, et al. Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles. J. Pharm. Sci. 1980, 69: 199–202.

Coscia, M. & Biragyn, A. Cancer immunotherapy with chemoattractant peptides. Semin. Cancer Biol. 2004, 14, 209–218.

Cullinane, C. et al. An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer Res. 2005, 65, 9633–9636

Curiel, T. J. Tregs and rethinking cancer immunotherapy. J. Clin. Invest.2007, 117, 1167–1174

Curley SA, Izzo F, Delrio P, et al. Radiofreqiency ablation of unresected primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999, 230: 1-8

Curley SA, Marra P, Beaty K, et al. Early and late omplication after radiofrequency ablation of malignant liver tumors in 608 patients. Annals of Surgery 2004, 239(4): 450-8

Cuvier C, Roblot-Treupel L, Millot JM, et al. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. Biochem. Pharmacol. 1992, 44: 509–517

Cyjon A, Neuman-Levin M., Rakowsky E, et al. Liver metastases from colorectal cancer: regional intra-arterial treatment following failure of systemic chemotherapy. British Journal of cancer 2001, 85, 4: 504-508.

Czarnota, G. J. et al. Ultrasound imaging of apoptosis: high-resolution non-invasive monitoring of programmed cell death in vitro, in situ and in vivo. Br. J. Cancer 1999, 81, 520–527.

Damm-Welk C, Fuchs U, Wossmann W, Borkhardt A. Semin. Cancer. Biol. 2003, 13: 283.

D’Angelica M, Kornprat P, Gonen M et al. Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: A matched case-control study. Ann Surg Oncol 2007;14:759 –765.

Darnell, R. B. & Posner, J. B. Observing the invisible: successful tumor immunity in humans. Nat. Immunol. 4, 201 (2003).

Dawson SL, Lee MJ, Mueller PR. Nonsurgical treatment of liver tumors: semionars in interventional radiology. Radiology 1993, 10:2

Day, S. E. et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nature Med. 2007, 13, 1382–1387.

Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer2005;5:275-84

DeBaere T, Bessoud B, Dromain C, et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR 2002, 178: 53-59

Decailliot F, D. Cherqui and B. Leroux, Effects of portal triad clamping on hemodynamic conditions during laparoscopic liver resection. Br J Anaesth 87 (2001), pp. 493–496.

De Gramont, A., Bosset, J.F., Milan, C.: Randomised trial comparing monthly low-dose leucovorin and fluorouracil bolus with bomonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a french intergroup study. J. Clin. Oncol., 1997, 15, 808-815.

De Gramont, A, Figer, A., Seymour, M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol., 2000, 18: 2938-2947

DeLaney TF, Smith AR, Lomax A, et al. Proton beam radiation therapy. Principles & Practice of Oncology Updates. Philadelphia, Pa: JB Lippincott; 2003;17:1-10

Dell’Agnola, C. & Biragyn, A. Clinical utilization of chemokines to combat cancer: the double-edged sword. Expert Rev. Vaccines 2007, 6, 267–283.

Diebold SS, Kursa M, Wagner E, et al. Mannose Polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 1999; 274: 19087-19094

Dionigi R, MadariagaJ. New technologies for liver resection. 1th ed. Basel, Karger Landes systém 1997, 1-267

Dobson J. Key-note lecture: Applicaions of magnetic nanoparticles in biology and medicine. Presented at the New Frontiers in Nanomedicine. Hammersmith Hospital Conference center, London, October 2007

Dodd GD, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threashold of a major breakthrough. Radio Graphics 2000, 20: 9-27

Dodd GD, Frank MS, Aribandi M, et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlaping ablations. AJR 2001, 1777: 777-82

Donnenberg VS, Donnenberg AD.Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis.J Clin Pharmacol 2005;45:872-7

Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000, 355: 1041-7

Drábková J. Účinky kapnoperitonea během laparoskopické cholecystektomie, Anesteziol, res. a IM 2001; 5:204-212

Duke Univerzity. Genomic Signatures of Drug Sensitivity Can Predict Response to Treatment J Clin Oncol. 2007;25:4350–4357.

Elias D., Baere de T, Roche A., et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of liver parenchyma. Br J Surg 1999, 86: 784-8

Elias D, Youssef O, Sideris L et al. Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 2004;86:4 –9.

Ellis LM, Curley SA, Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 2005; 23:4853– 4855.

Emens, L. A., Reilly, R. T. & Jaffee, E. M. Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity. Endocr. Relat. Cancer 2005 12, 1–17.

Faivre J, Rat P, Arveux P. Epidemiologie des metastases hepatiques des caners de colon. In Nordlinger B, Jaeck D (eds.). Traitment des metastases hepatiques des cancers colorectaux. Paris 1992, Springer Verlag,: 2-9

Farges O, Belghiti J, Kainmanesh R, et al. Portal vein embolization before right hepatecomy: prospective clinical trial. Ann Surg 2003, 237: 208-17

G. Ferzli, A. David and T. Kiel, Laparoscopic resection of a large hepatic tumor. Surg Endosc 9 (1995), pp. 733–735.

Fire A, Xu S, Montgomery MK, et al. Nature 1998, 391: 806

Florek M et al. 2005, Cell Tissue Res 319: 15-26

Fong Y, Blumgart LH. Surgical options in the treatment of hepatic metastases for colorectal cancer. Curr Probl Surg 1996; 35:336–413

Fong Y, Kemeny N, Paty P, et al. Treatment of colorectal cancer: hepatic metastasis. Semin Surg Oncol 1996;12:219–252.

Fong Y, Cohen AM, Fortner J,G, et al. Liver resection on colorectal metastases. JCO 1997, 15: 938-46

Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309 –318; discussion 318–321.

Franklin, R. J. M. et al. Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. NeuroReport 1999, 10, 1–5

Gabizon AA. Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy. Cancer Invest. 2001, 19, 424–436.

M. Gagner, M. Rheault and J. Dubuc, Laparoscopic partial hepatectomy for liver tumor. Surg Endosc 6 (1992), p. 99.

Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).

Gambhir, S. S. Molecular imaging of cancer with positron emisson tomography. Nature Rev. Cancer 2002, 2, 683–693.

Garufi C, et al. Letter to the Editor. J Clin Oncol 2006, p.2217-2218

Gautam A, Densmore CL, Xu B, Waldrep JC. Mol. Ther. 2000, 2: 63.

Gee, M. S. et al. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res. 2001, 61, 2974–2982.

Geryk E, Kolcová V, Žáček V. Trendy počtů onkologických nemocných v České republice. Občanské sdružení podpory zdraví a onkologické prevence v Brně, Brno, 2000

Giacchetti, S., Perpoint, B., Zidani, R., et al. Phase III multicenter randomised trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J.Clin.Oncol. 2000, 18: 136-147

Gigot JF, D. Glineur, J. Santiago Azagra, M. Goergen, M. Ceuterick et al., Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 236 (2002), pp. 90–97.

Gillams AR. Thermal ablation of liver metastases. Abdom Imaging 2001, 26: 361-8

Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004, 14: 2261-7

Glimelius B, Isacsson U, Blomquist E, et al. Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncol. 1999;38:137-145

Gloor B, Q. Ly and D. Candinas, Role of laparoscopy in hepatic cyst surgery. Dig Surg 19 6 (2002), pp. 494–499.

Glunde, K., Jacobs, M. A. & Bhujwalla, Z. M. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev. Mol. Diag. 2006, 6, 821–829.

Goin JE, Salem R, Carr BI et al. Treatment of unresectable hepatocellular carcinomas with intrahepatic yttrium-90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 2005, 16: 161-4

Goldberg SN, Stein M, Gazelle GS, et al. Percutaneous radiofrequency tissue ablation: optimization of pulsed RF technique to increase coagulation necrosis. J Vasc Interven Radiol 1999, 10: 907-16

Goldberg SN, Ahmed M, Gazelle GS, et al. Radiofrequency thermal ablation with NaCl solution injection: effect of elestrical conductivity on tissue heating and coagulation – phantom and porcine liver study. Radiology 2001, 219: 157-65

Goldberg RM, Sargent DJ, Morton RF, at al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated colorectal cancer. J Clin Oncol 2004, 22: 23-30

Golman, K., in ‘t Zandt, R. & Thaning, M. Real-time metabolic imaging. Proc. Natl Acad. Sci. USA 2006, 103, 11270–11275.

Golman, K. & Petersson, J. S. Metabolic imaging and other applications of hyperpolarized 13C. Acad. Radiol. 2006, 13, 932–942.

Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58

Gottschalk S, Cristiano RJ, Smith LC, Woo SLC. Folate receptor-mediated DNA delivery into tumor cells: protosomal disruption results in enhanced gene expression. Gene Ther 2001; 1: 185-191

Gray BN, Anderson JE, Burton MA, et al. Regression of liver metastases following treatment with yttrium-90 mirospheres. Aust N Z J Surg 1992, 62: 105-10

Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients wih liver metastases from primary large bowel cancer. Ann Oncol 2001, 12: 1711-20

Griesmayer E, Auberger T. The status of MedAustron. Radiother. Oncol. 2004; 73Suppl 2:p202-5

Grosse S, Aron Y, Honore I, et al. Lactosylated polyethylenimine for gene transfer into airway epithelial cells: Role of the sugar moiety in cell delivery and intracellular trafficking of the complexes. J Gene Med 2004; 6: 345-356.

Grothey A, Sargent D, Goldberg RM, et al. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004, 22: 1209-14

Gruenberger T, Sorbye H, DeboisMet al. Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM). Interim results of EORTC Intergroup randomized phase III study 40983. J Clin Oncol 2006;24(18 suppl):3500.

Guo W, et al. Pediatr.Res. 2006, 59: 59R-64R

Gyves J, Ensminger W, Niderhuber J, et al. : Totally implanted systém for intravenous chemotherapy in patients with cancer. Amer.J.Med., 73, 1982, p.841-5

Haddad FF, Chapman WC, Wright JK, et al. Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998;75:103–108.

Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006. Eur J Surg Oncol 2006;32:473– 483.

Harewood, Baron, Rumala, Wang: Pilot study to Assess Patient outcomes Following Endoscopic Application of photodynamic Therapy for Advanced Cholangicarcinoma, JGH, 2005, 20(3), 415-420

Helmebeger T Holzknecht N, Schopf U, et al. Radiofrequency ablation of liver metastases. Technique and initial results. Radiologe 2001, 41: 69-76

Herba MJ, Thirlwell MP. Radioembolization for hepatic metastases. Semin Oncol 2002, 29: 152-9

Hiraki T, Kanazawa S. Hepatic outflow obstruction created by baloon occlusion of hepatic vein: induced hepatic hemodynamic changes and the therapeutic applications of hepatic venous occlusion with a baloon catheter in interventional radiology. Acta Medica Okayama 2005, 59: 171-8

Hirko A, Tang F, Hughes JA. Cationic lipid vectors for plasmid DNA delivery. CurMed Chem 2003; 10: 1185-1193

Holubec L jr, Sutnar A, Topolčan O, et al. Role adhezivních molekul v procesu metastazování u kolorektálního karcinomu. in Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater - Abstrakta. 1. vyd. Plzeň : Euroverlag s.r.o., 2003. s. 15

Huitzil-Melendez F, Capanu M, Haviland D et al. Evaluation of the impact of systemic (SYS) neoadjuvant chemotherapy (neoadj) in patients (pts) with resectable liver metastasis (mets) from colorectal carcinoma (CRC) treated with adjuvant hepatic arterial infusion (HAI) and SYS chemotherapy. Presented at the 2007 Gastrointestinal Cancers Symposium, Orlando, FL, January 21, 2007.

Hurwitz HI, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350: 2335-2342.

Chang, J. et al. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer 2000, 89, 2145–2152.

Chapman WC, Debelak JP, Wright Pinson C, et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg 2000;231:752–761.

Chapman WC, Debelak JP, Blackwell TS, et al. Hepatic cryoablation-induced acute lung injury: pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg 2000;135:672–673.

Chen P, Wang J, Hope K, et al. Nuclear localizing sequences (NLS) promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. J Nucl Med. 2006;47:827–836.

Chiannilkulchai N, Ammoury N, Caillou B, et al. Hepatic tissue distribution of doxorubicin-loaded particles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. Cancer Chemother. Pharmacol. 1990, 26: 122–126.

Church J et al.: Characteristics of management of dominant inherited colorectal carcinoma. DCR 2003, 46(8),1001-5

Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999, 29: 1099-1105

Jager, P. L. et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J. Nucl. Med. 2001, 42, 432–445.

Jain RK, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 307: 58-62

Jersenius U., Fors D., Rubertsson S, Arvidsson D. Laparoscopic parenchymal division of the liver in a porcine model: comparison of the efficacy and safety of three different techniques Surg Endosc 2007; 21: 315-320

Jiao LR, Szyszko T, Al-Nahhas A, et al. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours. 2007

Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006, 355: 1253-61

Jung, H. I., Kettunen, M. I., Davletov, B. & Brindle, K. M. Detection of apoptosis using the C2A domain of synaptotagmin, I. Bioconjug. Chem. 2004, 15, 983–987

Kala Z, Kiss I, Válek V, Kysela P, et al. Multidisciplinární přístup k jaterním malignitám ve FN Brno - model onkologické indikační komise. In Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater - Abstrakta. 1. vyd. Plzeň : Euroverlag s.r.o, 2003. s. 18-18. ISBN 80-7177-794-3

Kala Z, Gál R, Procházka V, Kysela P, et al. Minimalizace krevních ztrát u velkých jaterních resekcí. In Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater - Abstrakta. 1. vyd. Plzeň : Euroverlag s.r.o., 2003. s. 19-19

Kala Z, Kysela P, Válek V. Intéret de la radiofréquence dans les résections hépatiques atypiques pour tumeur maligne - Étude préliminaire a propos de 5 cas. Le journal de Coelio-chirurgie 2003, 48: 32-35

Kala Z, Válek V, Kysela, et al. Laparoscopic hepatic resections using heat coagulation necrosis - 3-years experience. Acta Chirurgica Belgica 2003, suppl 103, 5: 47-48,

Kam NWS, Liu Z, Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew Chem Int Ed Engl. 2006;45:577–581.

Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol. 2002;20:4466-4471

Kamel IR. State of the art – imagin of the liver. presented at thAnual course in HPB surgery and transplantation. Hammesmith Hospital Campus, October 2007.

Kankaanranta L, Seppälä T, Koivunoro H, et.al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):475-82.

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53: 457-81.

Karoui M, Penna C, Amin-Hashem M et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006;243:1–7.

Kavolius J, Fong Y, Blumgart LH. Surgical resection of metastatic liver tumors. Surg Oncol Clin North Am 1996;5:337–352.

Kemeny N, Huang Y, Cohen AM, et al.Hepatic arterial infusion of chemotherapy after resection of hepatis metastases of colorectal cancer. N Engl J Med 1999, 341: 2039-48

Kemeny N, Jarnagin W, Gonen M et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003;21:3303–3309.

Kemeny N, Eid A, Stockman J et al. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma. J Surg Oncol 2005;91:97–101.

Karande P, Jain A, Mitragotri S. Natur. Biotechnol. 2004, 22: 192.

Kaufmann, B. A. & Lindner, J. R. Molecular imaging with targeted contrast ultrasound. Curr. Opin. Biotechnol. 2007, 18, 11–16.

Kelly K, Alencar H, Funovics M, et al. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res. 2004, 64, 6247–6251.

Kettunen MI, Brindle KM. Apoptosis detection using magnetic resonance imaging and spectroscopy. Prog. Nucl. Mag. Reson. Spectrosc. 2005, 47, 175–185.

Khambata-Ford S, Baselga J, et al. J Clin Oncol. 2007;25:3230-3237

King W, Proffitt J, Morrison L et al.: The role of fluorescence in situ hybridization in molecular diagnostics and disease management. Mol Diagn 2000, 5(4): 309-19,

Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8: 28-40

Knight SJ, Flint J.: Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet. 2000, 37(6): 401-9

Kohne, C.M., Schoffski, P., Wilke, H.: Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: Results of a randomised trial in patients with advanced colorectal cancer. J.Clin.Oncol., 1998, 16, 418-426

Koivasalo AM, Lindgren L., Effects of carbon dioxide pneumoperitoneum for laparoscopic cholecystectomy Act. Anaesth. Scand 2000; 9: 834-841

Kondo T. Eur J cancer 2006, 42: 1237-42

Kooby DA, Fong Y, Suriawinata A et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003;7: 1034–1044.

Kunath K, Von Harpe A, Fischer D, Kissel T. Galactose-PEI-DNA complexes fortargeted gene delivery: degree of substitution affects complex size and transfection efficiency. J Control Release 2003; 88: 159-172

Kunath K, Merdan T, Hegener O, Haeberlein H, Kissel T. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med 2003; 5: 588-599

Kune GA, Kune S, Field B et al., Survival in patients in large bowel cancer: a population based investigation from Melbourne colorectal cancer study. Dis Colon Rectum 1990, 33, 938-46,

Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002, 132: 605-12

Kysela, Petr - Boudný, Jaroslav - Válek, Vlastimil - Ondrášek, Jiří - Kiss, Igor. Locoregional chemotherapy of the liver without the laparotomy. Acta Chirurgica Belgica, Belgie, suppl. 103, 5, od s. 51-51, 1 s. ISSN 001-5458. 2003

Kysela P, Boudný J, Válek V, et al. Náš přístup k regionální chemoterapii jater. In Současné možnosti v diagnostice a léčbě primárních a sekundárních nádorů jater Plzeň 11.-12.6.2003 - Abstrakta. 1. vyd. Plzeň : Euroverlag sro, Bolzanova 5, 320 25Plzeň, 2003. s. 23-23. ISBN 80-7177-794-3.

Kysela P, Kala Z, Mannová J. Notes on laparoscopic liver surgery. International workshop on laparoscopic liver surgery, Cluj-Napoca, Romania, 26.3-29.3.2008.

Lal G, Gallinger S, Familial adenomatous polyposis. Semin Surg Oncol, 18(4): 314-23, 2000

Lal PBS., Lee KF. Wong J Techniques for liver resection: a review 2007 Surgeon 5; 3:168-74

Lee D, Choi SW, Kim M et al.: Discovery of differentially expressed genes related to histological subtype of hepatocellular carcinoma. Biotechnol prog. 19(3): 1011-5, 2003

Leggett BA, Young JP, Barker M : Peutz-Jeghers syndrome – genetic screening. Expert Rev Anticancer Ther, 3(4): 518-24, 2003

Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radio-frequency ablation of hepatic colorectal metastases. technique, indications results and new promises. Invest Radiol 2004, 39: 689-97

Lentschener C., Ozier Y. Anaesthesia for elective liver resection: some points should be revisited Eur. J. of Anaesthesiology 2002; 19: 780-788

Levi F, Lucchini F, La Vecchia C, Negri E. Trends in mortality from cancer in the European Union 1955-1994. Lancet 1999, 354, 742-3

Lewandowski RJ, Thurston KG, Goin JE et al. 90Y microsphere treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy measured by FDG-PET and CT imaging. J Vasc Interv Radiol 2005, 16: 1641-51

Liersch T, Meller J, Kulle B, et al. Phase II Trial of Carcinoembryonic Antigen Radioimmunotherapy With 131I-Labetuzumab After Salvage Resection of Colorectal Metastases in the Liver: Five-Year Safety and Efficacy Results. Journal of Clinical Oncology. 2005; 23: 6763-6770.

Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the „test of time aproach“. Cancer 2003, 97: 3027-35

Loeffler JS, Smith AR, Suit HD. The potential role of proton beams in radiation oncology. Semin Oncol. 1997;24:686-695

Lowenberg B, Sonneveld P. Resistance to chemotherapy in acute leukemia. CurrOpin Oncol 1998;10:31-5

Lutsiak, M. E. et al. Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 2005, 105, 2862–2868.

Madoff DC, Abdalla EK, Vauthey EK. portal vein embolisation in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005, 16: 779-90

Madoff DC, Abdalla EK, Gupta S, et al. Transhepatic ipsilateral portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 2005, 16: 215-25.

Makuuchi M, Tahi BL, Takayasu K, et al. Preoperative portal viembolisation to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990, 107: 521-7

T. Mala, B. Edwin, I. Gladhaug, E. Fosse, O. Soireide, A. Bergan et al., A comparative study of the short term outcome following open and laparoscopic liver resection of colorectal metastases. Surg Endosc 16 7 (2002), pp. 1059–1063.

Mantel N. Evaluation of survival dataand two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports, 1966, 50 (3): 163-70.

Marelli L, Stigliano R, Triantos C, et al.Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007 Jan-Feb;30(1):6-25

Marra G, Boland R, : HNPCC: the syndrome, the genes and historical perspectives (review). J of the National Cancer Institute 1995, 87: 1114-1125,

Marshall E. What to do when clear success comes with an unclear risk? Science 2002; 298: 510-511

Martin R, Paty P, Fong Y et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197:233–241, discussion 241–242.

Matsuzaki Y, Osuga T, Chiba T, et al. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma. Intern Med. 1995;34:302-304

Mayer R, Mock U, Jäger R, et al.Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). Radiother. Oncol. 2004; 73Suppl 2:24-8

McManus MT. Semin. Cancer. Biol. 2003, 13: 253

Meng A, Wang Y, Van Zant G, Zhou D. Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells. Cancer Res 2003;63:5414-9.

Merdan T, Callahan J, Petersen H, et al. Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem 2003; 14: 989-996

Meta-Analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 1998, 16: 301-8

Metzler M, Wilda M, Busch K, et al. Genes Chromosomes Cancer 2004, 39: 167

Meyers MA. Neoplasms of the digestiva tract: imaging, staging, and management. 1st ed. Philadelphia:Lippincot Raven, 1998, Dodd GD, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threashold of a major breakthrough. Radio Graphics 2000, 20, 9-27

Michael MZ, O´Connor SM, van Holst Pellekaan NG, et al. Mol. Cancer Res. 2003, 1: 882.

Michaelis, L. C. & Ratain, M. J. Measuring response in a post-RECIST world: from black and white to shades of grey. Nature Rev. Cancer 2006, 6, 409–414

Miller FH, Keppek AL, Reddy D, et al. Response of liver metastases after treatment with Yttrium-90 microspheres: Role of size, necrosis and PET. AJR 2007, 188: 776-83

Minagawa M, Yamamoto J, Kosuge T et al. Simplified staging systém for predictingthe prognosis of patients with resectable liver metastases. Arch Surg 2007,142:269-76

Moffat, B. A. et al. Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc. Natl Acad. Sci. USA 2005, 102, 5524–5529.

Monsky WL, Kruskal JB, Lukyanov AN et al. Radiofrequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 2002, 224: 823-9.

Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation:multivariate meta-analysis and review of contributing factors. Ann Surg 2005, 242: 158-71

Muller H, Nakchbandi W, Chatzissavvidis I, et al. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony stimulating factor (GM-CSF) and chemoembolisation with melphalan in the treatment of disseminated colorectal liver metastases. European Journal of Surgical Oncology. 2001, 27: 652-61.

Munn, D. H. & Mellor, A. L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 2007, 117, 1147–1154.

Munzarova M : Genetic susceptibility to malignant diseases – ethical issues. Minireview. Neoplasma 2002, 49(1): 1-4,

Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175(suppl 2):57-63

Nakano I, Kornblum HI. Pediatr Res 2006, 59: 54R-58R

Navarra G, Ayav A, Weber JC, et al.: Short- and-long term results of intraoperative radiofrequency ablation of liver metastases. Int J Colorectal Dis 2005;20:521–528.

Nemati F, Dubernet C, Fessi H, et al. Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer. Int. J. Pharm. 1996,138: 237–246

Neves, A. A. et al. A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging. Nano Lett. 2007, 7, 1419–1423

Nishi S, Shindo M, Abe J. Clinical aspects of indocyanine green pharmacokinetics following portal vein administration Br J Clin Pharacol 1998; 45:41-47

Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases of the liver. Cancer 1996, 77: 1254-62,

Ntziachristos, V., Yodh, A. G., Schnall, M. & Chance, B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl Acad. Sci. USA 2000, 97, 2767–2772.

O´Brien CA et al. A Human colon cancer cell capable of initiating tumour groeth in immunodeficient mice. Nature 2007, 445: 106-110.

Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolozations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br.J.Surg 2006, 93: 1091-8

Oliver TG, Wechsler-Reya RJ. Neuron 2004, 42: 885-8

Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br.J Surg 2003, 90: 1240-43

Oxford Biomedica presents encouraging final phase II results with TROVAX® in colorectal cancer at the International Colorectal Cancer Congress. http://www.oxfordbiomedica.co.uk/news/2005-ob-31.htm

PACCE: Panitumumab advanced colorectal cancer evaluation study. Available at: http://clinicaltrials.gov/ct/show/NCT00115765?order=1) nebo (Intergroup CALGB 80405. http://www.cancer.gov/search/ResultsClinicalTrialsAdvanced.aspx?protocolsearchid=2851539

Pantarotto D, Partidos CD, Hoebeke J, et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol. 2003;10:961–966.

Pantarotto D, Briand J-P, Prato M, Bianco A. Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem Commun (Camb). 2004;16–17.

Pastorin G, Wu W, Wieckowski S et al. Double functionalization of carbon nanotubes for multimodal drug delivery. Chem Commun (Camb). 2006;1182–1184.

Pawlik TM, Izzo F, Cohen DS, et al. Combined resection and radiofrequency ablation of for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003, 10: 1059-69

Pellot-Barakat C, Sridhar M, Lindfors KK, Insana MF. Ultrasonic elasticity imaging as a tool for breast cancer diagnosis and research. Curr. Med. Imaging Rev. 2006, 2, 157–164.

Petrovsky A, Schellenberger E, Josephson L, et al. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 2003, 63, 1936–1942

Phan, G. Q. et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA 2003, 100, 8372–8377

Poptani, H. et al. Detecting early response to cyclophosphamide treatment of RIF-1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging. NMR Biomed. 2003, 16, 102–111

Pospíšilová Š, Brázda V, Kuchaříková K, et al. Activation of the DNA binding ability of latent p53 protein by proteinkinase C is abolished by proteinkinase CK2. Biochem J 2004, 378: 939-47

Raj GV, Moreno JG, Gomella LG.: Utilization of Polymerase chain reaction technology in the detection of solid tumors. Cancer (Phila.) 1998, 82: 1419-42

Rau HG, E. Buttler, G. Meyer, H.M. Schardey and F.W. Schildberg, Laparoscopic liver resection compared with conventional partial hepatectomy—a prospective analysis. Hepatogastroenterology 45 (1998), pp. 2333–2338.

Reilly RM, Kiarash R, Cameron RG, et al. 111In-Labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. J Nucl. Med. 2000;41:429–438.

Reilly RM. Carbon nanotubes: potential Benefits and Risks of Nanotechnology in Nuclear Medicine. The journl of Nulear Medicine 2007, JUL, 48/7, 1039-42

Rengucci C, Maiolo P, Saragoni L et al.: Multiple detection of Genetic alterations in tumors and stool. ClinCancer res 2001, 7: 590-93

Rhim H, Yoon KH, Lee JM, et al. Major complications after radiofrequency thermal ablation of hepatic tumors: spectrum of imaging findings. RadioGraphics 2003, 23: 123-36

Rhim H, Dodd GD 3rd, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographicsnm2004, 24: 41-5

Ribero D, Abdala EK, Madoff DC, et al. portal vein embolization before majore hepatecomy and its effects on regeneration, resectability and outcome. Br J Surg 2008, in press

Ricci-Vittiani L et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445: 111-115

Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000, 217: 119-26

Rubbia-Brandt L, Audard V, Sartoretti P, et al: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004, 15:460-466

Rubbia-Brandt LR, Tumor edge post chemotherapy. Annual Course in HPB Surgery and transplantation. 8th-10th Oct. 2007, Hammersmith Conference Centre, London

Sadelain M. Insertional oncogenesis in gene therapy: how much of a risk? Gene Ther 2004; 11: 569-573

Sakamoto I, Aso N, Nagaoki K, et al. Complications associated with transcatheter arterial embolization for hepatic tumors. RadioGraphics 1998; 18:605-619.

Saltz, I.B., Cox, J.V., Blanke, C., Rosen, L.S., Fehrenbacher, L., Moore, M.J: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer . Irinotecan study group. N.Engl.J.Med., 2000, 343, 905-914

Saltz L, Lenz H, Kindler HL, et al. Interim report of randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer. Program and abstracts of the American Society of Clinical Oncology 2005 Gastrointestinal Cancers Symposium; January 27-29, 2005; Hollywood, Florida. Abstract 169b.

Salvador-Morales C, Townsend P, Flahaut E, et al. Carbon 2007, 45:607-17.

Salvador-Morales C, Basiuk EV, Basiuk AV, et l. J.Nanosci.Nanotechnol. 2007, was in press.

Sarantou T, Bilchik A, Ramming KP. Complications of hepatic cryosurgery. Semin Surg Oncol 1998;14:156–162.

Sato K, Lewandowski RJ Nui JT, et al. Treatment of inresectable primary and metastatic liver cancers with yttrium-90 microspheres (Therasphere): assessment of the hepatic arterial embolization. Cardiovasc Intervent Radiol 2006, 29:522-29

Sauer R, Becker H, HohenbergerWet al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–1740.

Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999;23:113–114.

Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided persutanous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994, 74: 817-25.

Seregni E, Ferrari L, Martinetti A, Bombardieri E : Diagnostic and prognostic tumor markers in the gastrointestinal tract. Semin Surg Oncol. 2001, 20(2): 147-66

Shaw IM, Rees M, Welsh FK, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable longterm survival. Br J Surg. 2006;93(4):457-464.

Shibata T, Niinobu T, Ogata N, Takami M. Mocrowave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000, 89(2): 276-84

Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys. 1995;32:3-12

Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection or hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999, 188: 304-9

Schell SR, Wessels FJ, Abouhamze a, et al. Pro- and anti-inflamatory cytokine Production after Radiofrequency Ablation of Unresectable Hepatic Tumors. J Am Coll Surg 2002, 195: 774-81

Schellenberger, E. A. et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol. Imaging 2002, 1, 102–107.

Scherer LJ, Rossi JJ. Natur. Biotechnol. 2003, 12: 1457.

Schoenthaler R, Castro JR, Petti PL, et al. Charged particle irradiation of sacral chordomas. Int J Radiat Oncol Biol Phys. 1993;26:291-298

von Schulthess, G. K., Steinert, H. C. & Hany, T. F. Integrated PET/CT: Current applications and future directions. Radiology 2006, 238, 405–422.

Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response and suvival. J Vasc Interv Radiol 2005, 16: 1627-1639

Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys. 2004;58:631-640

Simillis C, Constantinides VA, Tekkis PP, et al. Laparoscopic versus open hepatic resections for benign and malignant neoplasms – a meta-analysis. Surgery. 2007, 141 (2): 203-11.

Singh SK et al. Identification of a Cancer Stem Cell in Human Brain Tumors. Cancer Res 2003, 63: 5821-5828.,

Singh SK et al. Identification of human brain tumour initiating cells. Naure 2004, 432: 396-401,

Singh SK et al. 2004, Oncogene 23: 7267-73

Siperstein A, Garland A, Engle K et al. Local recurrence after laparoscopic radiorequency thermal ablation of hepatic tumors. Ann Surg Oncol. 2007, 7: 106-113.

Sipkins, D. A. et al. Detection of tumour angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nature Med. 1998, 4, 623–626

SIRTEX Medicl: EC-SIR-SPHERES. User´s manual.

Sitharaman B, Kissell KR, Hartman KB, et al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun (Camb). 2005;3915–3917.

Skřivanová K, Škorpíková J, Švihálek J, et al. Photochemical properties of a potential photosensitiser indocyanine green in vitro. Journal of Photochemistry and Photobiology B:Biology 2006, 85: 150-154

Smith AM, Shelton RM, Harris JJ, Perrie Y. J-Pharm.Pharmacol. 2005, 57: 42.

Smith AM, et al. Photoactive liposomes in tissue ingeneering. presented at the New frontiers in nanomeicine, London Hammersmith Hospital Conmference, October 16, 2007.

Smith GL, Zagha RM, Libertino JA. Description of Technique and Initial Results: The Habib 4X Bipolar resection Device in Open Nephron Sparing Surgery Without Renal Artery Occlusion. Lahey Clinic Abstract 2007, Burlington Massachusetts

Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled tip electrodes. Radology 1997, 205: 367-73

Sorensen SM, Mortenses FV, Nielsen DT. Radiofreqiency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007, 48: 253-8

van Steenis JH, van Maarseveen EM, Verbaan FJ, et al. Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J Control Release 2003; 87: 167-176

Stevenson, FK, Rice, J, Ottensmeier, CH, Thirdborough, SM and Zhu, D (2004). DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Immunol Rev 199: 156–180.

Stewart GJ, Preketes A, Horton M, et al. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology 1995;32:215–219.

Stone MD, Cady B, Jenkins RL, et al. Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 1990, 125: 718

Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J gastrointest Surg 2001, 5: 292-302.

Su, H. et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clin. Cancer Res. 2006, 12, 5659–5667

Subar DA, Sheen AJ, Sherlock DJ, et al. Cryoablation of liver tumors – is there clinical utility? Med Gen Med 2003, 7: 5-19

Sudheendra D, Neeman Z, Kam A, et al. Intermittent hepatic vein baloon occlusion during radiofrequency ablation of the liver. Cardiovasc Interv Radiology 2006, 29: 1088-92.

Sullivan RD, Nercross JW, Watkins E jr. Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964, 270: 321-7

Suzuki, Inaba, Yokoi, Ohata, Ota, Photodynamic therapy for malignant biliary obstruction : a cas series, Endoscopy 2004, 36: 83-7

Sweeney RA, Vogele M, Wegmazr A, Lukas P, Auberger T. The patient positioning concept for the planned MedAustron centre.Radiother. Oncol. 2004; 73Suppl 2: 64-7

Szebeni J, Baranyi L, Savay S, et al. Role of complement activation in hypersenzitivity reactions to Doxil and Hynic PEG liposomes: Experimental and cilinical studies. Journal of Liposome Research, 2002, 12:1, 165 – 172

Szebeni J, et al. Mechanisms and approaches for the prevention of adverse immune reactions to nanomedicines. presented at New frontiers in nanomedicine, Hammersmith Hospital Conference Centre, London October 2007

Šachlová M, Foretová L : Intestinal polyposis syndrome and the genetics of colorectal carcinoma. Klin Onkol., 11: 107-12, 1998

Takagi S, Hepatic and portal vein blood flow during carbondioxide pneumoperitoneum for laparoscopic hepatectomy. Surg Endosc 12 (1998), pp. 427–431.

Takahashi Y, Teshima T, Kawaguchi N, et al. Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res.  2003; 63(14):4253-7

Takamizawa J, Konishi H, Yanagisawa K, et.al. Cancer Res. 2004, 64: 3753.

Tam W, Ben-Yehuda D, Hayward WS Mol. Cell. Biol. 1997, 17: 1490

Tanaka K, Shimada H, Matsuo K et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650–659.

Taylor MD et al. 2005, Cancer Cell 8: 323-335

Terraz S, Constantin Ch, Majno P, et al. Image-guided multipolar radiofrequency ablation of liver tumours: initial clinical results. Eur Radiol 2007, 21

Therasse, P. et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 2000, 92, 205–216.

Thirion P, Michielis S, Pignogn, et al. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an update meta-analysis. The Meta-Analysis Group In Cancer. J.Clin Oncol 2004, 22: 3766-3775.

Tisman G, MacDonald D, Shindell N, et al. Oxaliplatin Toxicity Masquerading As Recent Colon Cancer. J Clin Oncol 2004, : 3202-4

Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N. Limited but definitive efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 2000, 88: 1549-1556

G. Torzilli, P. Leoni, A. Gendarini, F. Calliada, N. Olivari and M. Makuuchi, Ultrasound-guided liver resections for hepatocellular carcinoma. Hepatogastroenterology 49 43 (2002), pp. 21–27.

Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004, 22: 229-237

Treupel L, Poupon MF, Couvreur P, Puisieux P. Vectorisation of doxorubicin in nanospheres and reversion of pleiotropic resistance of tumor cells. C. R. Acad. Sci. 1991, III 313/17 : 1–174.

Uziely B, Jeffers S, Isacson R, et al. Liposomal Doxorubicin: Antitumor Activity and Unique Toxicities During two Complementary Phase I Studies. J. Clin. Oncol. 1995, 13, 1777–1785.

Válek V.: Maligní obstrukce žlučových cest: 5 let zkušeností s léčbou Wallstentem a brachyterapií- prospektivní randomizovaná studie. Čes. Radiol. 2000, 54, (2): 92 – 96

Válek V, Kala Z, Kiss I, et al. Maligní ložiskové procesy jater. Diagnostika a léčba včetně minimálně invazivnívh metod. 1. vyd., Praha 2006, Grada Publishing.

Válek V, KyselaP, Kala Z, et al. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study. European journal of radiology, 2007, 62, 2: 175-9

Van den Berg A, Kroesen BJ, Kooistra K, et al. Genes Chromosomes Cancer 2003, 37: 20.

Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy vs fluorouracil/leucovorin hemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004, 88: 78-85

Vauthey JN, Chaoui A, Do KA, et al. Standardozed measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000, 127: 512-19

Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in western adults. Liver Transpl. 2002, 8: 233-40,

Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and increase in ninety-day mortality after surgery for hepatic colorectal metastasis. J Clin Oncol 2006, 2004: 2065-72

de Verdière AC, C. Dubernet, et al. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br. J. Cancer 1997, 76: 198–205.

Verdun C, Brasseur F, Vranckx H, Couvreur P, Roland M. Tissue distribution of doxorubicin associated with polyhexylcyanoacrylate nanoparticles. Cancer Chemother. Pharmacol. 1990, 26: 13–18.

Vogl TJ, Straub R, Eichler K, et al. Malignant liver tumors treated with MR imaging-guided laser-inducet thermotherapy experience with complications in 899 patients (2.520 lesions). Radiology 2002, 225: 367-77

Vogl TJ, Straub R, Eichler K, et al. Colorectal carcinoma metastasis in liver: Laser-induced Interstitial Thermotherapy – Lol tumor control rate and survival data. Radiology 2004, 230: 450-458.

Voorhees PM, Dees EC, O'Neil B, Orlowski RZ. The proteasome as a target for cancer therapy. Clin. Cancer Res. 2003, 9 (17): 6316-25.

Washington K, Debelak JP, Gobbell C, et al. Hepatic cryoablation-induced acute lung injury. Histopathologic findings. J Surg Res 2001;95:1–7.

Wang Y, Schulte BA, Larue AC, Ogawa M, Zhou D. Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood 2006;107:358-66

Weber JC, Navarra G, Jiao LR, et al.: New technique for liver resectionusing heat coagulative necrosis. Ann Surg 2002;236: 560–563.

Weber JC, Bachellier P, Oussoultzoglou E et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003; 90: 956 –962.

Weber WA. Positron emission tomography as an imaging biomarker. J. Clin. Oncol. 2006, 24, 3282–3292.

Weissleder, R., Tung, C.-H., Mahmood, U. & Bogdanov, A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nature Biotech. 1999, 17, 375–378.

Wieder H, et al. PET imaging with [11C]methyll-methionine for therapy monitoring in patients with rectal cancer. Eur. J. Nuc. Med. Mol. Imaging 2002, 29, 789–796.

Wicha MS, et al. Cancer Res 2006, 66: 1883-90

Wilson RR. Radiological uses of fast protons. Radiology. 1946;47: 487-491.

Winter, P. M. et al. Molecular imaging of angiogenesis in nascent vx-2 rabbit tumors using a novel αvβ3-targeted nanoparticle and 1.5 Tesla magnetic resonance imaging. Cancer Res. 2003, 63, 5838–5843

Wong CO, Savin M, Sherpa KM, et al. Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy refractory metastatic liver carcinoma. Cancer Biother Radiopharm 2006, 21: 305-13

Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Annals of Surgical Oncology 2000, 7(8):593-600

Woodword-Richens K, Bevan S, Churchman M: Analysis fo genotypic and phenotypis heterogenity in juvenile polyps. Gut, 46(5): 656-60, 20

Wrightson WR, M.J. Edwards and K.M. McMasters, The role of the ultrasonically activated shears and vascular cutting stapler in hepatic resection. Am Surg 66 (2000), pp. 1037–1040.

Yoon CHJ, Chung JW, Park JH. Transcatheter arterial chemoemboliyation with paclitaxel-lipiodol solution in rabbit VX2 liver tumor. Radiology 2003, 229, 126-131

Yoshimoto, M. et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: Acetate metabolism in tumor cells. Nucl. Med. Biol. 2001, 28, 117–122.

Yun, S. H. et al. Comprehensive volumetric optical microscopy in vivo. Nature Med. 2006, 12, 1429–1433.

Zacharoulis D, Asopa V, Navarra G, et al.: Hepatectomy using intraoperative ultrasound-guided radiofrequency ablation. Int Surg 2003;88:80–82.

Zhang JS, Liu F, Huang L. Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev 2005; 57: 689-698

Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B. & Brindle, K. M. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nature Med. 2001, 7, 1241–1244.

Zhu, D. & Stevenson, F. K. DNA gene fusion vaccines against cancer. Curr. Opin. Mol. Ther. 2002 4, 41–48.

Zorko M, Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 2005; 57: 529-545